0001209191-23-048615.txt : 20230907 0001209191-23-048615.hdr.sgml : 20230907 20230907162158 ACCESSION NUMBER: 0001209191-23-048615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nuss John CENTRAL INDEX KEY: 0001874108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 231242542 MAIL ADDRESS: STREET 1: C/O VENTYX BIOSCIENCES, INC. STREET 2: 332 ENCINITAS BLVD. SUITE 200 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12790 EL CAMINO REAL, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-05 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001874108 Nuss John C/O VENTYX BIOSCIENCES, INC. 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 Chief Scientific Officer 0 Common Stock 2023-09-05 4 M 0 10000 0.20 A 254815 D Common Stock 2023-09-05 4 S 0 6991 32.2439 D 247824 D Common Stock 2023-09-05 4 S 0 3009 33.4142 D 244815 D Stock Option (right to buy) 0.20 2023-09-05 4 M 0 10000 0.00 D 2030-05-01 Common Stock 10000 6778 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022. Represents the weighted average share price of an aggregate total of 6,991 shares sold in the price range of $31.97 to $32.935. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 3,009 shares sold in the price range of $32.98 to $33.9549. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 1, 2020. /s/ Christopher Krueger, as Attorney-in-Fact 2023-09-07